About Apnimed Inc
Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders.
Apnimed Inc (APMD) Stock Score & Signals
Apnimed Inc (APMD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry. Its current 2BB score is 59 out of 100.
2BB score and signals
Apnimed Inc’s current 2BB score is 59 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 77 | High |
| Momentum | 49 | Stable |
| Financial strength | 37 | Weak |
| Quality | 82 | Very Strong |
| Risk | 63 | High (provisional) |
Company facts
| Founded | 2017 |
| Employees | 81 |
| 52-week range | $16.12 – $35.29 |